Claudia Ros-Alcaraz, Maria Camila Erazo-Puentes, Octavi Camps-Font, Marta García-García, Rui Figueiredo, Eduard Valmaseda-Castellón
{"title":"Outcomes of Surgical Treatment of Peri-implantitis: A Retrospective Cohort Study","authors":"Claudia Ros-Alcaraz, Maria Camila Erazo-Puentes, Octavi Camps-Font, Marta García-García, Rui Figueiredo, Eduard Valmaseda-Castellón","doi":"10.11607/jomi.11018","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess the risk of recurrence or disease progression in patients with peri-implantitis who underwent surgical treatment.</p><p><strong>Materials and methods: </strong>A retrospective cohort study was carried out in patients subjected to peri-implant surgery between 2015 and 2021 with a minimum follow-up of 12 months. Data were analyzed using simple binary logistic regression models at the patient level and generalized estimation equations at the implant level.</p><p><strong>Results: </strong>A total of 34 patients and 103 implants were analyzed (70 of the implants received resective techniques and 33 of the implants received regenerative procedures). Fifteen patients (44.12%) experienced peri-implantitis recurrence and one patient (2.9%) lost an implant. No differences were found between the surgical techniques (P = .56). The following factors were found to increase the risk of recurrence: a history of periodontitis (OR = 4.62; 95% CI: 1.14–18.75) (P = .032), maxillary location (OR = 9.69; 95% CI: 1.81– 51.87) (P = .008), and two implants treated per procedure (OR = 31.68; 95% CI: 3.91– 256.54) (P = .001).</p><p><strong>Conclusions: </strong>Almost half of all patients (44%) undergoing surgical treatment of peri-implantitis will present disease progression or recurrence. This risk seems to be higher in patients with several treated implants, with a history of periodontal disease, or with implants placed in the maxilla.</p>","PeriodicalId":94230,"journal":{"name":"The International journal of oral & maxillofacial implants","volume":"0 0","pages":"591-598"},"PeriodicalIF":1.7000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The International journal of oral & maxillofacial implants","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11607/jomi.11018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To assess the risk of recurrence or disease progression in patients with peri-implantitis who underwent surgical treatment.
Materials and methods: A retrospective cohort study was carried out in patients subjected to peri-implant surgery between 2015 and 2021 with a minimum follow-up of 12 months. Data were analyzed using simple binary logistic regression models at the patient level and generalized estimation equations at the implant level.
Results: A total of 34 patients and 103 implants were analyzed (70 of the implants received resective techniques and 33 of the implants received regenerative procedures). Fifteen patients (44.12%) experienced peri-implantitis recurrence and one patient (2.9%) lost an implant. No differences were found between the surgical techniques (P = .56). The following factors were found to increase the risk of recurrence: a history of periodontitis (OR = 4.62; 95% CI: 1.14–18.75) (P = .032), maxillary location (OR = 9.69; 95% CI: 1.81– 51.87) (P = .008), and two implants treated per procedure (OR = 31.68; 95% CI: 3.91– 256.54) (P = .001).
Conclusions: Almost half of all patients (44%) undergoing surgical treatment of peri-implantitis will present disease progression or recurrence. This risk seems to be higher in patients with several treated implants, with a history of periodontal disease, or with implants placed in the maxilla.